Agendia, Inc., a commercial stage company focused on precision oncology for breast cancer, today announced a multi-year partnership with Illumina, Inc. (NASDAQ: ILMN), to...
Therapixel, a company leading the use of AI-based products for women's health, announces it has received a second 510(k) clearance from the U.S. Food...
